Johnson & Johnson (J&J) has received approval from the US Food and Drug Administration (FDA) for its TECNIS PureSee extended depth of focus (EDOF) intraocular lens (IOL), designed for use in cataract ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

LIMERICK, IRELAND, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Johnson & Johnson MedTech*, a global leader in eye health, announced today that its TECNIS PureSee purely refractive presbyopia-correcting lens is ...

Johnson & Johnson (JNJ) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its Tecnis PureSee intraocular lens (IOL), giving eye surgeons a new lens option for use in ...

JACKSONVILLE, Fla., March 12, 2026--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) ...

Please provide your email address to receive an email when new articles are posted on . The presbyopia-correcting Tecnis PureSee IOL is now fully available in the U.S. The company launched a patient ...

Johnson & Johnson has launched the TECNIS PureSee™ intraocular lens in India, catering to individuals with presbyopia. The IOL features a purely refractive design, ensuring clear vision and minimal ...

“With the full U.S. availability of TECNIS PureSee IOL, we are expanding access to an important extended depth of focus option that reflects our commitment to innovation, visual quality, and patient ...

• Expanded U.S. availability paired with new patient lifestyle quiz encourages informed decision-making ahead of cataract surgery. • Cataracts are one of the leading causes of vision impairment. 1 ...

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260611210092/en/ The TECNIS SIMPLICITY™ Delivery System ...